SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A randomized phase 3 trial. ctDNA analysis of patients (pts) ...
The U.S. Space Force has awarded five companies positions on the Protected Tactical Satellite Communications-Global, or PTS-G, contract, which has a ceiling value of approximately $4 billion. Hear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback